Sign In
Buy ADC
$72.03
-0.650 (-0.89%)
At Close: Jun 03, 2026
Buy These 6-8% Yields For Drama-Free Income
08:30am, Monday, 16'th Mar 2026
Main Street Capital offers a 7.9% yield, robust ROE, low leverage, and a long NAV growth record, justifying its sector-leading premium. MAIN's internally managed BDC structure, low operating costs, an
- Confirmed response rates in expansion cohorts of 32% at 10 mg/kg Q3W dose and 20% at 8.6 mg/kg Q3W - - Estimated progression free survival of 7.1 months at 10 mg/kg and 6.8 months at 8.6 mg/kg - -
A Crude Awakening
09:00am, Sunday, 15'th Mar 2026
U.S. equities slid to four-month lows as the escalating Iran war rattled markets, sending oil to three-year highs and interest rates higher amid tanker attacks, shipping disruptions, and intensifying
Sutro Biopharma: ADC Developer With Poor Track Record Aims For Positive 2026
08:57am, Friday, 13'th Mar 2026
Sutro Biopharma is an early-stage ADC developer, trading at a $406m market cap after a strong 6-month rally. STRO's pipeline centers on next-generation ADCs, with lead candidate STRO-004 in Phase 1 an
Engineers Gate Builds $85 Million Position in Net-Lease Retail REIT Agree Realty
05:20pm, Thursday, 12'th Mar 2026
Engineers Gate Manager LP bought 1,144,617 Agree Realty (ADC) shares Quarter-end position value rose by $82.48 million, reflecting both the share increase and stock price changes This trade represente
Market Finally Pricing In Recession - 2 Dividend Stocks To Weather The Storm
07:00am, Thursday, 12'th Mar 2026
Agree Realty and Waste Management are highlighted as defensive, income-focused plays amid rising recession risks and market volatility. ADC boasts a 99.7% occupancy rate, investment-grade tenants, a n
Sell Alert: 3 Popular REITs To Avoid
07:15am, Wednesday, 11'th Mar 2026
Not every REIT is worth buying. Some popular names now look overvalued. Here are 3 REITs I would sell.
Agree Realty Declares Monthly Common and Preferred Dividends
04:05pm, Tuesday, 10'th Mar 2026
ROYAL OAK, Mich.--(BUSINESS WIRE)--Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced that its Board of Directors has authorized, and the Company has declared, a monthly cash div
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
07:30am, Tuesday, 10'th Mar 2026
LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7 anticipated by year-end 2026 Recent amendment to HealthCare Royalty financing agreement increases s
Agree Realty Corporation (NYSE:ADC) Receives Consensus Recommendation of “Moderate Buy” from Analysts
04:33am, Tuesday, 10'th Mar 2026
Agree Realty Corporation (NYSE: ADC - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fourteen brokerages that are presently covering the stock, MarketBeat.com repor
2 Tariff-Proof Retail Stocks to Buy Now
06:35am, Thursday, 05'th Mar 2026
Realty Income is a giant retail landlord with a 30-year history of dividend increases. Agree Realty is a U.S.-focused retail landlord that's been growing quickly.
Selecting A Near-Perfect Dividend Growth Machine For Uncertain Times
12:48pm, Tuesday, 03'rd Mar 2026
Global instability is rising fast, but one income strategy may be built for exactly this kind of environment. These overlooked income machines combine bond-like stability with built-in growth most inv
Time for Boomers to Play It Safe: Our 5 Safest Monthly Pay Dividend Stocks
08:18am, Tuesday, 03'rd Mar 2026
While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation.
ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026
07:15am, Tuesday, 03'rd Mar 2026
LAUSANNE, Switzerland, March 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced tha
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
04:05pm, Monday, 02'nd Mar 2026
LAUSANNE, Switzerland, March 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced tha
